Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
Rudolf Uher, Katherine E. Tansey, Tracy Dew, et al.
American Journal of Psychiatry (2014) Vol. 171, Iss. 12, pp. 1278-1286
Closed Access | Times Cited: 377

Showing 1-25 of 377 citing articles:

Major depressive disorder
Christian Otte, Stefan M. Gold, Brenda W.J.H. Penninx, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 1680
The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Eléonore Beurel, Marisa Toups, Charles B. Nemeroff
Neuron (2020) Vol. 107, Iss. 2, pp. 234-256
Open Access | Times Cited: 1414
Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential
Eiko I. Fried, Randolph M. Nesse
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 796
Inflammation: Depression Fans the Flames and Feasts on the Heat
Janice K. Kiecolt‐Glaser, Heather M. Derry, Christopher P. Fagundes
American Journal of Psychiatry (2015) Vol. 172, Iss. 11, pp. 1075-1091
Open Access | Times Cited: 682
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Vasiliki Michopoulos, Abigail Powers, Charles F. Gillespie, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 254-270
Open Access | Times Cited: 633
Inflammation and clinical response to treatment in depression: A meta-analysis
Rebecca Strawbridge, Danilo Arnone, Andrea Danese, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 10, pp. 1532-1543
Closed Access | Times Cited: 579
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Emanuele F. Osimo, Luke Baxter, Glyn Lewis, et al.
Psychological Medicine (2019) Vol. 49, Iss. 12, pp. 1958-1970
Open Access | Times Cited: 562
The Role of Inflammation in Depression and Fatigue
Chieh-Hsin Lee, Fabrizio Giuliani
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 514
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Ole Köhler‐Forsberg, Jesper Krogh, Ole Mors, et al.
Current Neuropharmacology (2016) Vol. 14, Iss. 7, pp. 732-742
Open Access | Times Cited: 454
Mechanisms and treatment of late-life depression
George S. Alexopoulos
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 438
The new field of ‘precision psychiatry’
Brisa S. Fernandes, Leanne M. Williams, Johann Steiner, et al.
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 434
Oxidative stress, inflammation and treatment response in major depression
Daniel Lindqvist, Firdaus S. Dhabhar, S. Jill James, et al.
Psychoneuroendocrinology (2016) Vol. 76, pp. 197-205
Open Access | Times Cited: 414
Treatment Selection in Depression
Zachary D. Cohen, Robert J. DeRubeis
Annual Review of Clinical Psychology (2018) Vol. 14, Iss. 1, pp. 209-236
Open Access | Times Cited: 392
What does plasma CRP tell us about peripheral and central inflammation in depression?
Jennifer C. Felger, Ebrahim Haroon, Trusharth Patel, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 6, pp. 1301-1311
Open Access | Times Cited: 352
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Jennifer C. Felger
Current Neuropharmacology (2017) Vol. 16, Iss. 5, pp. 533-558
Open Access | Times Cited: 344
Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials
Ole Köhler‐Forsberg, Cecilie N. Lydholm, Carsten Hjorthøj, et al.
Acta Psychiatrica Scandinavica (2019) Vol. 139, Iss. 5, pp. 404-419
Closed Access | Times Cited: 342
Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis
Jia Jia Liu, Ya Bin Wei, Rebecca Strawbridge, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 2, pp. 339-350
Closed Access | Times Cited: 333
Treatment-resistant depression and peripheral C-reactive protein
Samuel R. Chamberlain, Jonathan Cavanagh, Peter de Boer, et al.
The British Journal of Psychiatry (2018) Vol. 214, Iss. 1, pp. 11-19
Open Access | Times Cited: 323
What has serotonin to do with depression?
Philip J. Cowen, Michael Browning
World Psychiatry (2015) Vol. 14, Iss. 2, pp. 158-160
Open Access | Times Cited: 320
Biomarkers for depression: recent insights, current challenges and future prospects
Rebecca Strawbridge, Allan H. Young, Anthony J. Cleare
Neuropsychiatric Disease and Treatment (2017) Vol. Volume 13, pp. 1245-1262
Open Access | Times Cited: 320
Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression
Yuri Milaneschi, Femke Lamers, Michael Berk, et al.
Biological Psychiatry (2020) Vol. 88, Iss. 5, pp. 369-380
Closed Access | Times Cited: 302
Molecular pathways of major depressive disorder converge on the synapse
Gabriel R. Fries, Valeria Saldana, Johannes Finnstein, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 284-297
Open Access | Times Cited: 241
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression
Ole Köhler‐Forsberg, Henriette N. Buttenschøn, Katherine E. Tansey, et al.
Brain Behavior and Immunity (2017) Vol. 62, pp. 344-350
Closed Access | Times Cited: 239
Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder
Ebrahim Haroon, Alexander W. Daguanno, Bobbi J. Woolwine, et al.
Psychoneuroendocrinology (2018) Vol. 95, pp. 43-49
Open Access | Times Cited: 231
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 206
Page 1 - Next Page

Scroll to top